157 related articles for article (PubMed ID: 25348972)
1. Antipsychotics and osteoporosis: current awareness and practice in primary care.
Jones E
Br J Gen Pract; 2014 Nov; 64(628):562-3. PubMed ID: 25348972
[No Abstract] [Full Text] [Related]
2. Current guidelines and their recommendations for prolactin monitoring in psychosis.
Citrome L
J Psychopharmacol; 2008 Mar; 22(2 Suppl):90-7. PubMed ID: 18477625
[TBL] [Abstract][Full Text] [Related]
3. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Howes OD; Smith S; Aitchison KJ
Curr Med Res Opin; 2004 Oct; 20(10):1649. PubMed ID: 15462698
[No Abstract] [Full Text] [Related]
4. [Antipsychotic prescription assessment in general practice: metabolic effects].
Gignoux-Froment F; de Montleau F; Saravane D; Verret C
Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.
Grigg J; Worsley R; Thew C; Gurvich C; Thomas N; Kulkarni J
Psychopharmacology (Berl); 2017 Nov; 234(22):3279-3297. PubMed ID: 28889207
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management.
González-Rodríguez A; Labad J; Seeman MV
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109941. PubMed ID: 32243999
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
8. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010.
Gallini A; Gardette V; Oumouhou N; Andrieu S; Donohue JM
Psychiatr Serv; 2015 Apr; 66(4):434-7. PubMed ID: 25588416
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopy beyond dermatology: evaluating its use in plastic and oral and maxillofacial surgery.
King ICC; Greaney L
Br J Oral Maxillofac Surg; 2018 Oct; 56(8):774-775. PubMed ID: 30093184
[No Abstract] [Full Text] [Related]
10. Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?
O'Keane V; Meaney AM
J Clin Psychopharmacol; 2005 Feb; 25(1):26-31. PubMed ID: 15643097
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs, menstrual regularity and osteoporosis risk.
Zhang-Wong JH; Seeman MV
Arch Womens Ment Health; 2002 Nov; 5(3):93-8. PubMed ID: 12510211
[TBL] [Abstract][Full Text] [Related]
12. [Hyperprolactinemia and antipsychotics: it's not always what it seems to be].
Brandsma AE; van der Doelen RHA; Ester WA
Tijdschr Psychiatr; 2021; 63(3):209-214. PubMed ID: 33779976
[TBL] [Abstract][Full Text] [Related]
13. Adherence to the Malaysian clinical practice guideline for depression by general practitioners in private practice in Penang.
Ho KC; Russell V; Nyanti L; Chan MW; Hassali MA; Dawood OT; Subramaniam K; O'Brien FM
Asian J Psychiatr; 2020 Feb; 48():101899. PubMed ID: 31901584
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
Alqarni NA; Hassan AH
Saudi Med J; 2018 Dec; 39(12):1218-1225. PubMed ID: 30520504
[TBL] [Abstract][Full Text] [Related]
16. Primary care staff's views and experiences related to routinely advising patients about physical activity. A questionnaire survey.
Douglas F; Torrance N; van Teijlingen E; Meloni S; Kerr A
BMC Public Health; 2006 May; 6():138. PubMed ID: 16719900
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents.
Naidoo U; Goff DC; Klibanski A
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():97-108. PubMed ID: 12650684
[TBL] [Abstract][Full Text] [Related]
18. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
[TBL] [Abstract][Full Text] [Related]
19. Clinical Management of Antipsychotic-Induced Hyperprolactinemia.
Wong-Anuchit C
Perspect Psychiatr Care; 2016 Apr; 52(2):145-52. PubMed ID: 25772527
[TBL] [Abstract][Full Text] [Related]
20. Effect of subspecialty training and experience on agreement with HIV guidelines.
Horsburgh CR; Gordin FM; Schaier S; Silver R
J Gen Intern Med; 1997 Aug; 12(8):518-9. PubMed ID: 9276664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
